About DarioHealth
DarioHealth is a publicly listed company based in New York (United States) founded in 2011. Chronic conditions are managed via a personalized digital platform. DarioHealth has raised $6.01 million across 27 funding rounds from investors including Driehaus, Perceptive Advisors and Manchester Capital Management. The company has 202 employees. DarioHealth has completed 4 acquisitions, including PhysiMax, Twill and Upright Pose. Its chief executive, as recorded, is Erez Raphael. Its website dariohealth.com draws about 30 thousand monthly visits. Its Indian entity Qloni Industries Limited reported revenue of ₹42.61 Cr. DarioHealth offers products and services including Cardiometabolic Solution, Musculoskeletal Solution, and Behavioral Health Solution. Its focus areas include HealthTech, Disease Self Management, Diabetes and Monitoring. Its competitors include Welldoc, Pear Therapeutics and Spiras Health; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2011 and headquartered in New York, United States, DarioHealth operates in the health technology sector. A mobile app is provided for tracking blood sugar levels, monitoring carbohydrate intake, and identifying health trends. Personalized coaching, behavioral insights, and AI algorithms are integrated to support routine management of chronic conditions like diabetes. Services are delivered digitally to users across various regions.
- Indian entity revenue₹42.61 Cr
FY 2023 · +1% YoY
- Indian entity net profit₹8.5 Lakh
FY 2023 · 0% margin
- Indian entity EBITDA₹8.6 Lakh
FY 2023 · 0% margin
- Total Equity Funding$6.01M (USD)
in 27 rounds
- Latest Funding Round$17.5M (USD), Post-IPO
Sep 2025
- InvestorsDriehaus
& 5 more
- Employee Count202
- Investments & AcquisitionsPhysiMax
& 3 more
Associated legal entities of DarioHealth
DarioHealth operates through Qloni Industries Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Qloni Industries Limited CIN U01405TG2015PLC099971 | Active | 29 Jul 2015 | Hyderabad, Telangana | ₹42.6 Cr | 3 | View details |
Products & Services of DarioHealth
DarioHealth offers a comprehensive portfolio of products and services, including Cardiometabolic Solution, Musculoskeletal Solution, and Behavioral Health Solution.
Manages diabetes, hypertension, and weight through personalized digital tools.
Improves strength, mobility, and reduces pain via guided exercises.
Addresses anxiety, depression, and stress with evidence-based support.
Apps and channels of DarioHealth
DarioHealth publishes 2 mobile apps with over 100K+ downloads; its YouTube channel DarioHealth has 1.8K subscribers and 30 videos.
Videos from DarioHealth
The most watched videos on DarioHealth's YouTube channel, DarioHealth (1.8K subscribers). Click a video to play it here.
More on DarioHealth.
Funding Insights of DarioHealth
DarioHealth has successfully raised a total of $6.01M across 27 strategic funding rounds. The most recent funding activity was a Post-IPO round of $17.5 million completed in September 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.01M
- Total Rounds 27
- Last Round Post-IPO — $17.5M
- First Round $805,000
(Oct 2011)
- Investors Count 6
Latest 10 of 27 funding rounds of DarioHealth with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2025 | $17.5M | Post-IPO | – | – | – |
| Dec 2024 | $25.6M | Post-IPO | – | – | – |
| Feb 2024 | $22.42M | Post-IPO | – | – | – |
| May 2023 | $15.4M | Post-IPO | – | – | – |
| Jan 2021 | $70M | Post-IPO | – | – | |
| Jul 2020 | $28.6M | Post-IPO | – | – | |
| Dec 2019 | $21.38M | Post-IPO | – | – | – |
| Dec 2018 | $3M | Post-IPO | – | – | – |
| Sep 2018 | $10.35M | Post-IPO | – | – | – |
| Feb 2018 | $6.62M | Post-IPO | – | – | – |
6 investors in total: 6 institutional.
Investors in DarioHealth
DarioHealth has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Driehaus, Perceptive Advisors and Manchester Capital Management.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Health-tech companies are targeted for venture capital investments. | 1999 | perceptivelife.com | New York, United States | |
| soleuscapital.com | ||||
Seed & early stage Digital Health focused VC firm funding companies in Israel | qureventures.com | Herzliya, Israel | ||
Fund investment management services are provided by Driehaus in Chicago. | 1982 | driehaus.com | Chicago, United States | |
Fundamentally-driven firm investing in micro-cap stocks with long and short strategies. | 2004 | nantahalapartners.com | New Canaan, United States | |
Multi-family office services are provided for wealth management. | 1992 | mcmllc.com | Manchester, United Kingdom |
Investor details for DarioHealth
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Qloni Industries Limited (DarioHealth)
Qloni Industries Limited is the primary company behind DarioHealth. The board of Qloni Industries Limited currently have 3 directors; the longest-serving is Manbodh Kumar Singh, appointed in 2018. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Manbodh Kumar Singh DIN 08091471 | Director | 22 Mar 2018 | 8 yrs 7 mo | Qloni Industries Limited |
| Rajesh Kumar Meena DIN 08517188 | Director | 23 Jul 2019 | 7 yrs 3 mo | Qloni Industries Limited |
| Shish Pal Singh DIN 08517189 | Director | 23 Jul 2019 | 7 yrs 3 mo | Qloni Industries Limited |
People of DarioHealth
55 people are tracked at DarioHealth (22 in leadership, 11 in board & advisors, 22 in team); the tracked headcount is 202.
| Name | Role | Group |
|---|---|---|
Erez Raphael | CEO | Leadership |
Dror Bacher | COO | Leadership |
Dave Auslander | VP of Data | Leadership |
Zvi Ben-David | CFO | Leadership |
Rick Anderson | President & GM, North America | Leadership |
Omar Manejwala | Chief Medical Officer | Leadership |
Boris Shusterman | Director Of Solution Architecture | Leadership |
Penny Westbury | Senior Director, Member & Customer Support Operations | Leadership |
Dov Oppenheim | Co-founder And Production Manager | Leadership |
Tarun Jain | Vice President For India Operations & Board Member | Global Org. Development Manager | Leadership |
Yifat Fundoiano-Hershcovitz | VP Of Clinical And Scientific Affairs | Leadership |
Lyr Ben Aharon | Program Director, B2b Accounts | Leadership |
Anat Gonen | VP Delivery | Leadership |
Tomer Meydad | VP R&d | Leadership |
Shai Admoni | Director Of Finance | Leadership |
Lauren Hartel | Director, Client Delivery | Leadership |
Zvika Erlich | Director Of Finance And Fp&a | Leadership |
Ami Haelion | Senior Vice President Of Operation And Connected (medical) Devices At Dario Health | Leadership |
Sean Schnapp | Director Of Finance And Accounting | Leadership |
Stephen Flynn | Senior Vice President | Leadership |
35 more people are available in the full profile.
Complete people profiles for DarioHealth
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of DarioHealth
DarioHealth is a publicly listed company on the NASDAQ with ticker symbol DRIO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date13 Oct 2014
- Listed onNASDAQ: DRIO
- Listed entityDarioHealth Corp.
- Exchange sectorHealth technology
- ISINUS23725P3082
- Share price$5.54 (+2.21% on the day) · 2026-10-13
- Market capitalisation$54.3M
- EPS (diluted, trailing year)$-7.49
- Volume (last session)9,072
Financials of DarioHealth
Figures of Qloni Industries Limited, the primary company behind DarioHealth, for FY 2023. Revenue was ₹42.61 Cr (+1% year on year). Net profit was ₹8.5 Lakh (0% margin). EBITDA was ₹8.6 Lakh (0% margin). Revenue has grown at a compounded annual rate of +1% over three years and +15% over five years.
- ₹42.61 CrRevenue · FY 2023 · +1% YoY
- ₹8.5 LakhNet profit · 0% margin
- ₹8.6 LakhEBITDA · 0% margin
- ₹10 LakhPaid-up capital
- +1%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $22.4M | -$20.3M | -$33.1M |
| 2024 | $27.0M | -$30.1M | -$48.7M |
| 2023 | $20.4M | -$54.9M | -$50.8M |
| 2022 | $27.7M | -$60.0M | -$53.5M |
| 2021 | $20.5M | -$76.8M | -$72.1M |
Balance sheet, profit and loss, cash flow and ratios of Qloni Industries Limited are on its company page.
Detailed financial statements for DarioHealth
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by DarioHealth
DarioHealth has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include PhysiMax, Twill and Upright Pose.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Evidence-based digital therapeutics and wellness apps for healthcare are provided. | twill.health | New York, United States | 2017 | Feb 2024 | $10M | |
Cloud-based sports analytics | pmax.co | Tel Aviv, Israel | 2012 | Jan 2022 | •••• | |
AI and SaaS-based mental health management software for employees and individuals | wayforward.io | New York, United States | 2014 | May 2021 | $30M | |
Wearable posture correction devices and mobile applications are developed. | uprightpose.com | Tel Aviv, Israel | 2012 | Jan 2021 | $31M |
Complete acquisition details for DarioHealth
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of DarioHealth
8 dated milestones of DarioHealth across 14 years, from founding to its latest funding, stage changes and deals.
- Founded DarioHealth is founded.
- Funding First funding round of $805K.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Upright Pose.
- Acquisition Acquires wayForward.
- Acquisition Acquires PhysiMax.
- Acquisition Acquires Twill.
- Funding Latest funding round, Post-IPO, of $17.5M.
Competitors of DarioHealth
DarioHealth has 3 listed competitors in our database, 3 of them funded. They include Welldoc, Pear Therapeutics and Spiras Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| welldoc.com | 2005 | Columbia, United States | $72.08M | 65 | Mobile health products for chronic disease management are offered. | |
| peartherapeutics.com | 2013 | Boston, United States | $266.34M | 207 | Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively. | |
| spirashealth.com | 2015 | Nashville, United States | $14.15M | 37 | Asthma and COPD symptoms are managed through clinical services. |
Detailed competitors of DarioHealth
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of DarioHealth
The website of DarioHealth (dariohealth.com) receives about 30.3K visits a month.
- Monthly visits30.3K
▲ 61% vs previous month
Websites whose visitors overlap most with DarioHealth. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
moneytalksnews.com | moneytalksnews.com | 100% | #51,674 | – | |
dariorestaurant.com | dariorestaurant.com | 84% | #3,221,430 | – | |
texomacareweightloss.com | texomacareweightloss.com | 76% | #2,732,206 | – |
Top companies in Health Monitoring & Wearables
3 companies that operate in the same segment as DarioHealth (Health Monitoring & Wearables) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Smart fitness equipment and streaming platforms are provided. | 2011 | New York, New York, United States | USD 995.53 M | USD 2.45 B | 2,894 | |
Wearable glucose monitoring patches are provided for real-time data tracking. | 1999 | San Diego, California, United States | USD 52.5 M | USD 4.66 B | 10,300 | |
Diabetes management is enabled via glucose meters and mobile apps. | 2010 | Palo Alto, California, United States | USD 201 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dariohealth
Complete news archive for DarioHealth
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DarioHealth
DarioHealth was founded in 2011.
DarioHealth is headquartered in New York, United States. It is registered at New York, New York, United States.
Erez Raphael is the CEO of DarioHealth, as recorded in our data.
DarioHealth is a funded company, having raised a total of $6.01M across 27 funding rounds to date. The company's 1st funding round was a Post-IPO of $6.62M, raised on Oct 2011.
DarioHealth has 202 employees.
The primary company behind DarioHealth, Qloni Industries Limited, reported revenue of ₹42.61 Cr for FY 2023, up 1% year on year.
Founded in 2011 and headquartered in New York, United States, DarioHealth operates in the health technology sector. A mobile app is provided for tracking blood sugar levels, monitoring carbohydrate intake, and identifying health trends. Personalized coaching, behavioral insights, and AI algorithms are integrated to support routine management of chronic conditions like diabetes. Services are delivered digitally to users across various regions.
DarioHealth's top competitors include Welldoc, Spiras Health and Pear Therapeutics.
DarioHealth offers Cardiometabolic Solution, Musculoskeletal Solution, and Behavioral Health Solution.
Yes, DarioHealth is publicly traded on NASDAQ under the ticker symbol DRIO.
DarioHealth has made 4 acquisitions, including PhysiMax, Twill, and Upright Pose.
DarioHealth has 6 investors. Key investors include Driehaus, Perceptive Advisors, Manchester Capital Management, Nantahala Capital Management, and Soleus Capital.